Anti-CD8 alpha antibody [SP239]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Advanced Validation
- Recombinant
- What is this?
3
(1 Review)
|
(49 Publications)
Anti-CD8 alpha antibody [SP239] (ab178089) is a rabbit monoclonal antibody detecting CD8 alpha in IHC-P, mIHC. Suitable for Human.
- Multiplex IHC validated on the Leica BOND® MAX using Opal reagents
- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications
View Alternative Names
CD8a, MAL, CD8A, T-cell surface glycoprotein CD8 alpha chain, T-lymphocyte differentiation antigen T8/Leu-2
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [SP239] (AB178089)
Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling CD8 alpha with ab178089 at followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on human tonsil, performed on a Leica Biosystems BOND® RX instrument. Counterstained with Paraffin-embedded sections. Hematoxylin Secondary antibody only control : Used PBS instead of primary antibody.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [SP239] (AB178089)
Immunohistochemical analysis of formalin-fixed, paraffin-embedded human tonsil tissue labeling CD8 alpha with ab178089 at 1/100 dilution.
- mIHC
Supplier Data
Multiplex immunohistochemistry - Anti-CD8 alpha antibody [SP239] (AB178089)
Multichannel (Multiplex) immunohistochemistry analysis of Formalin/PFA-fixed paraffin-embedded sections of human tonsil tissue labeling NKG2D, NKG2a, and CD8 alpha. Panel A : merged staining of anti-CD8 alpha (red; Opal™690), anti-NKG2A (gray; Opal™520) and anti-NKG2D (green; Opal™570) on human tonsil. Panel B : anti-NKG2D (ab302907 at 1 : 2000 dilution (0.258 μg/ml)) signal on NK cells and T cell subsets. Panel C : anti-NKG2A (ab260035 at 1 : 2000 dilution (0.283 μg/ml)) signal on NK cells. Panel D : anti-CD8 alpha (ab178089 at 1 : 100 dilution (0.83 μg/ml)) signal on T cell subsets. Opal Polymer HRP Ms + Rb was used as secondary antibody. The section was incubated in three rounds of staining : in the order of ab178089, ab260035, and ab302907 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins. Nuclear counterstain was DAPI. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.
- mIHC
Supplier Data
Multiplex immunohistochemistry - Anti-CD8 alpha antibody [SP239] (AB178089)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human tonsil labelling PD1 with ab243644 at 1/500 dilution (1.02 µg/mL) (D), CD8 with ab178089 at 1/100 dilution (0.83 μg/ml) (C) and TIM 3 with ab242080 at 1/500 dilution (2.09 μg/ml) (B). Opal Polymer HRP Ms + Rb was used as a secondary antibody, and DAPI was used for a nuclear counter stain. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins. Panel A : merged staining of anti-TIM 3 (green; Opal™690), anti-CD8 (red; Opal™520) and anti-PD1 (gray; Opal™570) on human tonsil. Panel B : anti-TIM 3 stained on membrane of a subset of immune cells. Panel C : anti-CD8 stained on membrane of a subset of T cells. Panel D : anti-PD1 stained on membrane of a subset of lymphocytes. The section was incubated in three rounds of staining : in the order of ab242080, ab243644 and ab178089 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [SP239] (AB178089)
Immunohistochemical analysis of formalin fixed paraffin embedded Human tonsil labelling CD8 with ab178089 at a concentration of 1 µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.
ab178089 anti DCD8 antibody SP239 was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)
Related conjugates and formulations (7)
-
Anti-CD8 alpha antibody [SP239] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD8 alpha antibody [SP239]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-CD8 antibody [SP239]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CD8 antibody [SP239]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CD8 antibody [SP239]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD8 antibody [SP239]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-CD8 alpha antibody [SP239]
Reactivity data
Product details
What is this antibody validated in?
Anti-CD8 alpha antibody [SP239] (ab178089) is a rabbit recombinant monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P), Multiplex IHC (mIHC) in Human samples.
Collaboration
Anti-CD8 alpha [SP239] (ab178089) is a clone from the portfolio of Spring Bioscience (Roche) SP clones which have been optimised for immunohistochemistry (IHC).
Trusted by the scientific community
Anti-CD8 alpha [SP239] (ab178089) was first used in a scientific publication in 2013 and has been cited over 20 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [SP239] also available for your convenience: ab178089, Carrier free - ab236230, Alexa Fluor® 488 - ab300091, Alexa Fluor® 647 - ab311158, Alexa Fluor® 594 - ab311806, Alexa Fluor® 568 - ab313089, Alexa Fluor® 555 - ab313283, Alexa Fluor® 750 - ab321212
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The CD8 alpha protein plays a critical role in T-cell mediated immune responses. It forms a heterodimer with the CD8 beta chain creating the CD8 alpha-beta complex that strengthens T-cell interaction with antigen-presenting cells. CD8 alpha also helps in signaling processes that activate T cells equipping them to destroy infected or malignant cells. Researchers often study CD8 alpha peptides to understand its interactions better.
Pathways
CD8 alpha is integral to the T-cell receptor signaling pathway and the cytotoxic T lymphocyte (CTL) pathway. The T-cell receptor complex which includes the CD8 molecule transmits signals that are important for T-cell activation and function. CD8 interacts with key proteins such as the T-cell receptor (TCR) and MHC class I molecules facilitating targeted responses against pathogens. These pathways highlight CD8 alpha's role in adaptive immunity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (49)
Recent publications for all applications. Explore the full list and refine your search
Journal of gastrointestinal oncology 16:1366-1379 PubMed40950351
2025
Applications
Unspecified application
Species
Unspecified reactive species
JCO precision oncology 9:e2500404 PubMed40749151
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 17: PubMed40723259
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 21:3827-3851 PubMed40607252
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1507348 PubMed40438604
2025
Applications
Unspecified application
Species
Unspecified reactive species
Current oncology (Toronto, Ont.) 32: PubMed40422521
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology, immunotherapy : CII 74:109 PubMed39937280
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 5:101807 PubMed39510070
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 50:102154 PubMed39405605
2024
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 10:eadi7764 PubMed39259785
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com